Up to $8,350,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • July 13th, 2015 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2015 Company Industry JurisdictionCyclacel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: